The biofilm lifestyle mode certainly represents one of the most successful behaviors to facilitate bacterial survival in diverse inhospitable environments. Conversely, the ability of bacteria to develop effective biofilms represents one of the major obstacles in the fight against bacterial infections. In Pseudomonas aeruginosa, the biofilm formation is intimately connected to the quorum sensing (QS) mechanisms, a mode of cell-to-cell communication that allows many bacteria to detect their population density in order to coordinate common actions. In this chapter, we propose an overview (i) on P. aeruginosa QS mechanisms and their implication in biofilm formation, and (ii) on natural products that are known to interfere with these QS mechanisms, subsequently disrupting biofilm formation. The concluding remarks focus on perspectives of these compounds as possible antibiotherapy adjuvants.
Introduction
Bacterial infections are mainly related to the ability of bacteria to invade and disseminate through their hosts by using different types of motility, by releasing a myriad of virulence factors, by building structured biofilm which lead to host cell and tissue damage but also allow bacteria to evade the immune system and conventional antimicrobial agents [1] . For decades, antibiotics, although less effective in biofilm-growing bacteria [2] , have represented our best weapon against bacterial diseases. However, the on-going emergence and worldwide spreading of resistant bacteria is considerably reducing the antibiotic pallet available for the treatment of bacterial infections [3] . This alarming situation forces researchers to consider other strategies to combat bacterial infections, notably the use of phages [4] or the use of alternative agents, such as essential oils [5] , silver nanoparticles [6] , bacteriocins [7] , and antimicrobial peptides [8] . Some interesting strategies propose original compounds that disrupt biofilm formation without affecting the viability of invading bacteria; this strategy is expected (i) to reduce the bacterial aptitude to build protective barriers, but without exerting a selective pressure per se [4] ; (ii) to allow sufficient time for the immune defenses to effectively destroy invaders; and (iii) to minimize the use of effective antibiotics.
In most bacteria, the expressions of virulence factors are coordinated by quorum sensing (QS) mechanisms, a cell-to-cell communication which allows bacteria to detect their population density by producing and perceiving diffusible signal molecules to synchronize common actions [9] . This cell-to-cell communication has been largely investigated in Pseudomonas aeruginosa, an opportunistic pathogen which mainly affects people who are severely immunocompromised, in part due to its ability to evade from both innate and acquired immune defenses through adhesion, colonization, and biofilm forming and to produce various virulence factors that cause significant tissue damage [10, 11] . In this bacterium, QS regulates virulence factors production, motilities and, in particular, biofilm formation for which QS is one of the relevant key actors. Interestingly, within the two past decades, study papers reporting natural and synthetic compounds that interfere with QS and/or biofilm formation are regularly published; QS circuitry and biofilm formation control mechanisms indeed constitute promising targets to struggle against P. aeruginosa infection with potential huge clinical interests [12] . The present chapter covers the scope of natural compounds from both prokaryote and eukaryote organisms that have been identified to disrupt the biofilm lifestyle cycle in P. aeruginosa via modulation of QS mechanisms. An overview of the entanglement between QS circuitry and biofilm formation is reported as a prerequisite for a better understanding of the mechanisms of action proposed for some of the identified compounds. The concluding remarks focus on the perspectives of these compounds as possible antibiotherapy adjuvants for possible eradication of resistant infections caused by P. aeruginosa.
P. aeruginosa biofilm lifestyle
Like most bacteria, P. aeruginosa can develop two distinct lifestyles, planktonic and sessile cells. The planktonic state is encountered when P. aeruginosa evolves freely in a liquid suspension, whereas on natural or synthetic surfaces, P. aeruginosa can form sticky clusters in permanent rearrangements characterized by the secretion of an adhesive and protective matrix [13] . Defined as "biofilm," this set of bacterial community adherent to a surface appears as an adaptive response to an environment more or less unsuited to growth in planktonic form [14] .
The biofilm formation can be delimited in five main stages (Figure 1 , image A). A first reversible phase corresponds to the initial adhesion of bacteria to surfaces; this adhesion becomes irreversible in the second stage (image B). Then, thanks to a proliferation period corresponding to the third stage, microcolonies are built concomitantly with the production of extracellular matrix (image C), leading to the fourth stage of biofilm structuration and organization in which the growth of three dimensional communities is observed with amplified extracellular matrix production (image D). This biofilm cycle is completed by a dispersion step (image E) [12] .
The secreted extracellular matrix mainly consists of proteins, nucleic acids, lipids, and exopolysaccharides (EPS). These account for 50-90% of total organic matter [16] . P. aeruginosa produces at least three types of EPS that are required for biofilm formation and architecture [17] . (i) Alginate a linear polysaccharide composed of L-guluronic and D-mannuronic acids linked by β-1,4 bonds [18] , (ii) Pel polysaccharide, a glucose-rich matrix material, with unclarified composition, and (iii) Psl polysaccharide, a repeating pentasaccharide consisting of D-mannose, L-rhamnose, and D-glucose. In mucoid strains, EPS are predominantly characterized by the presence of alginate. The alginate participates in the structuring of the
QS mechanisms and their implication in biofilm formation
The complex regulation of biofilm formation involves multiple bacterial machineries including the QS systems. In P. aeruginosa, this mechanism is involved in the development of various common bacterial behaviors, including virulence factors expression and biofilm formation, which are mostly implicated in infection success. Three QS systems have been clearly characterized: (i) the las system and the rhl system, two LuxI/R type systems using the signal molecules of the family of acyl-homoserine lactones (AHLs); and (ii) the PQS (pseudomonas quinolone signal) system based on molecules of the 2-alkyl-4-quinolone class [10, 31] . The mechanisms of QS in P. aeruginosa are summarized in Figure 2 while the main functions regulated by QS systems and involved in the pathogenesis of P. aeruginosa are presented in Figure 3 .
Evidence that the las system is implicated in biofilm formation has been firstly established when Davies et al. [32] demonstrated that the biofilm formed by lasI mutant appears flat, undifferentiated, and quickly dispersed from the surface upon exposure to sodium dodecyl sulfate, compared to wild type biofilms.
Furthermore, Gilbert et al. [33] observed the binding of the QS regulator LasR to the promoter region of the psl operon, suggesting that the psl expression may be regulated by the QS. Considering that the psl operon is implied in biofilm modulation, the QS then plays a role in the biofilm formation and architecture. The transcription of the pel operon seems to be reduced in rhlI mutant, suggesting that the rhl system plays a biofilm formation role in P. aeruginosa by modulating the biosynthesis of the Pel polysaccharide [34] . The pqsA mutant produces a biofilm with less eDNA than the wild type biofilm, suggesting that the PQS system also plays a role in biofilm formation, more particularly in the eDNA releasing [34] .
Notably, the production of rhamnolipids and lectins is under QS control, indicating a further indirect link between biofilm formation/degradation and QS.
Indeed, the rhl system controls the production of rhamnolipids [35] , that play multiple roles in P. aeruginosa biofilm formation: (i) as biosurfactant and virulence factor [36] ; (ii) in the formation of microcolonies [37] ; (iii) in the maintenance of open channel structures necessary for nutrient circulation [38] ; (iv) in the development of biofilm mushroom-shaped structures [37] ; and (v) in cell dispersion from the biofilm [39] . Indeed, a hyper-detaching property has been observed in the P. aeruginosa mutants that produce more rhamnolipids compared to wild type strains [40] . Moreover, the rhl system also controls the expression of the cytotoxic virulence factors LecA and LecB. Data obtained on mutant strains indicate that these galactophilic lectins probably contribute to the biofilm development [41, 42] . Similarly, two types of P. aeruginosa motilities implicated in biofilm formation are also QS-regulated. The first movement, swarming motility, accomplishes an organized surface translocation, dependent on cell-to-cell Systems involved in P. aeruginosa QS circuitry. The main QS systems in P. aeruginosa are the las, rhl, and PQS systems. The las system consists of a lasR regulatory gene coding for the LasR protein, a lasI gene coding for a LasI synthase involved in the synthesis of a signal molecule of the acyl-homoserine lactone (AHL) family, the 3-oxo-C12-HSL. The LasR/3-oxo-C12-HSL complex is a transcriptional activator of virulence genes (protease, elastase, and exotoxin) and lasI gene. According to the same model, the rhl system consists of rhlR, rhlI genes, and another AHL, the C4-HSL. This system activates genes in common with the las system and also specific genes, such as those coding for the synthesis of rhamnolipids, pyocyanin, and swarming/twitching motilities. The las system controls the rhl system. The third PQS system is interposed between the two main systems. The PqsABCDE operon produces the precursor 2-heptyl-4-quinolone (HHQ ), and PqsH catalyzes conversion of HHQ to 2-heptyl-3-hydroxy-4-quinolone (PQS), detected by the receptor PqsR [10, 31] .
Natural Compounds Inhibiting Pseudomonas aeruginosa Biofilm Formation by Targeting… DOI: http://dx.doi.org /10.5772/intechopen.90833 contacts and extensive flagellation [43] ; this has been observed during the first stage of P. aeruginosa biofilm development and seems to be regulated by the rhl system [44] . Flat and uniform biofilms are formed when the strains grow under conditions promoting swarming motility, for example, a growth medium with glutamate or succinate as carbon sources; by contrast, a biofilm without confluent cell aggregates is formed by strains with limited swarming motility [45] . The second movement, a flagella-independent form of translocation, is described as a successive extension and retraction of polar type IV pili [46] . This kind of movement, regulated by the rhl system on a Fe-limited minimal medium [47] , is necessary to assemble bacteria in monolayers that form microcolonies [38] .
Other mechanisms implied in biofilm formation
The QS systems are not the sole key actors intervening in biofilm formation by P. aeruginosa. Indeed, the complex regulation of biofilm formation involves multiple bacterial machineries that also include the membrane-bound sensor kinase GacS, the transcriptional response regulator GacA (GacS/GacA two-component regulatory system), and the intracellular second messenger bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP). Briefly, the GacS/GacA system acts as a super-regulator of the las and rhl systems [48] , whereas c-di-GMP is important for the biosynthesis of alginate and Pel polysaccharides and for the switch from planktonic to biofilm lifestyle [49] .
Natural products that affect QS and biofilm formation by Pseudomonas aeruginosa

From prokaryotes
Enzymes
Microorganisms known to have the ability to produce anti-QS enzymes are still limited to a few bacteria from the families of (i) Actinobacteria (Rhodococcus and Streptomyces); (ii) Firmicutes-Arthrobacter (Bacillus and Oceanobacillus); (Acinetobacter, Agrobacterium tumefaciens, Alteromonas, Comomonas, Halomonas, Hyphomonas, Klebsiella pneumoniae, P. aeruginosa, Ralstonia, Stappia, and Variovorax paradoxus) [50] [51] [52] [53] [54] [55] [56] .
Four types of enzymes are known to degrade AHLs [57, 58] , a phenomenon sometimes described as "quorum quenching" (QQ ) [59] ; these include AHLlactonases and decarboxylases that attack the lactone ring (Bacillus indicus, B. pumilus, and B. sp. SS4 cause significant inhibition of QS-dependent activities in Gram-negative bacteria such as P. aeruginosa PAO1, Serratia marcescens, and Vibrio), AHL-acylases that cleave the acyl side chain (B. pumilus S8-07 degrades 3-oxo-C12-HSL into the corresponding lauric acid [60] ), and deaminases that separate the lactone ring from the acyl side chain. Recently, lactonases and acylases were identified in Erythrobacter, Labrenzia, and Bacterioplanes found in Red Sea sediments; these both degrade AHLs of different acyl chain lengths, particularly the 3-oxo-C12-HSL, and inhibit the formation P. aeruginosa PAO1 biofilm [59] .
Mycobacteroides abscessus subspecies, emerging pathogens, are capable of degrading both PQS and HHQ. M. abscessus subsp. abscessus, in coculture with P. aeruginosa PAO1, reduced PQS levels through a PQS dioxygenase (encoded by the aqdC gene, M. abscessus subsp. massiliense, a recombinant strain overexpressing the aqdC gene, reduces the level of the virulence factors pyocyanin, pyoverdine, and rhamnolipids, suggesting that AqdC is a QQ enzyme [61] . Its impact on biofilm formation would have been interesting to investigate as another dioxygenase, the 2-alkyl-3-hydroxy-4(1H)-quinolone 2,4-dioxygenase (HodC), was described to cleave PQS, attenuate the production of virulence factors but conversely increase the viable biomass, in both newly formed and established biofilms, by increasing iron availability [62] .
Organic acids
The acetic and phenyl lactic acids, found in the supernatant of probiotic strains Lactobacillus paracasei subsp. paracasei CMGB isolated from newborn feces, were shown to inhibit, at nonbacteriostatic/bactericide levels, the expression of QS genes in P. aeruginosa, preventing adherence of bacteria to an inert substratum [63, 64] . Similarly, the lactic acid produced by a potential probiotic Pediococcus acidilactici M7 strain, also isolated from newborn feces, inhibits the production of P. aeruginosa short-chain AHLs, elastase, protease, pyocyanin, and biofilm as well as the swarming-swimming-twitching motilities [65] .
From fungi
Antibiotics and mycotoxins
Penicillin produced by Penicillium spp. has been shown to be effective in controlling a bacterial infection. Recently, about 33 Penicillium spp. have been recognized as producers of QS inhibitors such as the small lactone mycotoxins patulin and penicillic acid. The use of patulin can significantly reduce lung infection caused by P. aeruginosa on a mouse model. Interestingly, a synergy has been shown in vitro between patulin and tobramycin toward P. aeruginosa PAO1 biofilms, whereas patulin alone does not affect the development of biofilm [66] . Although the antiinfective property of patulin has been demonstrated, its genotoxicity and potential carcinogenic properties [67] probably preclude clinical applications.
Erythromycin, a macrolide antibiotic isolated from Saccharopolyspora erythraea, has been recently demonstrated to reduce virulence factors in P. aeruginosa PAO1, including various motilities, biofilm formation, and production of rhamnolipids, total protease, elastase, and pyocyanin at nonmicrobicidal level (1.6 μg/mL) [68] . Comparably, Natural Compounds Inhibiting Pseudomonas aeruginosa Biofilm Formation by Targeting… DOI: http://dx.doi.org /10.5772/intechopen.90833 the erythromycin derivate, azithromycin, shows a strong P. aeruginosa QS and biofilm inhibitory effect [69] [70] [71] with inhibition of alginate synthesis [69] , a reduction of each type of bacteria movement [72] and a diminution of gacA gene expression [73] . At weak antibiotic concentration (2 μg/mL), a biofilm inhibition is observed, probably explained by a lower production of both AHL signal molecules, C4-HSL and 3-oxo-C12-HSL, and of virulence factors [74] [75] [76] .
Alkylcyclopentanone
Recently, Kim et al. [77] indicated that the alkylcyclopentanone terrein, isolated from Aspergillus terreus, reduced virulence factors (elastase, pyocyanin, and rhamnolipids) and biofilm formation via antagonizing QS receptors without affecting P. aeruginosa cell growth. Beyond a negative impact on the production of QS signaling molecules and expression of QS-related genes, terrein also reduced c-di-GMP levels, an important secondary messenger for the switch from planktonic to biofilm lifestyle mode, by decreasing the activity of a diguanylate cyclase required for c-di-GMP biosynthesis [78] .
From Plants
Derivatives of shikimic acid, phenols, and polyphenols
Many phenolic compounds and derivatives with anti-QS and antibiofilm activities have been isolated from plants [79] . Cinnamaldehyde [the dominant compound of certain essential oils, in particular Cinnamomum camphora (L.) J. Presl] and its derivatives modulate a wide range of anti-QS and antibiofilm activities of P. aeruginosa [80] [81] [82] . Curcuma longa L. produces curcumin, which inhibits the expression of virulence genes of P. aeruginosa PA01 [83] .
Ellagic acid derivatives from Terminalia chebula Retz. downregulate lasIR and rhlIR genes expression and decrease AHLs production, leading to an attenuation of virulence factor production and to an enhanced sensitivity of biofilm facing a tobramycin treatment [84] .
Flavonoids have been investigated for their roles as QS modulating compounds. From these, naringenin and taxifolin reduced the expression of several QS-controlled genes (i.e., lasI, lasR, rhlI, rhlR, lasA, lasB, phzA1, and rhlA) in P. aeruginosa PAO1. Similarly, the flavan-3-ol catechin, extracted from the bark of Combretum albiflorum (Tul.) Jongkind, reduces the production of QS-dependent virulence factors, such as pyocyanin, elastase, and the formation of biofilm by P. aeruginosa PAO1 [85] . Interestingly, baicalin, an active natural compound extracted from the traditional Chinese medicinal Scutellaria baicalensis, has been demonstrated to inhibit the formation of P. aeruginosa biofilms and enhance the bactericidal effects of antibiotics such as amikacin. Moreover, at sub-minimal inhibitory concentration (256 μg/mL), this flavonoid has been shown to reduce LasA protease, LasB elastase, pyocyanin, rhamnolipids, and exotoxin A production and to downregulate the three QS-regulatory genes, including lasI, lasR, rhlI, rhlR, pqsR, and pqsA [86] . Consistently, in vivo experiments indicated that baicalin treatment reduces P. aeruginosa pathogenicity in Caenorhabditis elegans and enhances the clearance of P. aeruginosa from the peritoneal implants of infected mice.
Furocoumarins from grapefruit can inhibit the QS signaling (AHLs and AI-2) of V. harveyi BB886 and BB170 strains as well as biofilm formation in pathogens such as E. coli O157:H7, Salmonella typhimurium and P. aeruginosa [87] . These purified furocoumarins (dihydroxybergamottin and bergamottin), tested at the concentration of 1 μg/mL, cause 94% inhibition of autoinducers (AHLs) without affecting bacterial viability. Biofilm inhibition was up to 58.3 and 72%, respectively, for E. coli O157:H7 but modest for P. aeruginosa (27.3 and 18.1%, respectively).
Malabaricone C, a diarylnonanoid isolated from the bark of Myristica cinnamomea King inhibited the QS-regulated pyocyanin production and biofilm formation in P. aeruginosa PAO1 [88] .
A screening of various herbs revealed that a clove extract [Syzygium aromaticum (L.) Merr. Et Perry] inhibits QS-controlled gene expression (las and PQS systems) in P. aeruginosa with eugenol as major active constituent [89] . Recently, the effects of eugenol and its nanoemulsion on P. aeruginosa QS-mediated virulence factors and biofilm formation have been identified by Lou et al. [90] at a 0.2 mg/mL concentration. Similarly, the anthraquinone emodin from Rheum palmatum L., a traditional Chinese medicinal plant, was found to inhibit the P. aeruginosa biofilm formation at 20 μM, increasing the antibiotic activity of ampicillin [91] . Finally, the 6-gingerol, isolated from fresh ginger oil, reduces the production of several virulence factors, decreasing the mortality induced in mice by P. aeruginosa. A DNA microarray analysis revealed that the application of the 6-gingerol on biofilm-encapsulated cells downregulates several QS-related genes, notably those involved in the production of rhamnolipids, elastase, pyocyanin, all of which are involved in biofilm formation [92] .
Alkaloids
Recently, caffeine (a purine alkaloid) has been shown to inhibit AHLs production and swarming mobility in P. aeruginosa PAO1 without causing AHLs degradation [93] .
Terpenoids and Triterpenoids
The pentacyclic triterpenoid ursolic acid was identified as an inhibitor of biofilm formation from Diospyros dendo Welw, the tree used for ebony from Gabon, Africa [94] . Tested at a dose of 10 μg/mL, ursolic acid reduces biofilm formation by 79% in E. coli and 57-95% in V. harveyi and P. aeruginosa PAO1. Similarly, oleanolic acid inhibits the in vitro biofilm formation by S. aureus and P. aeruginosa [95] . However, these triterpenoids showed no inhibitory effect on QS mechanisms contrarily to triterpenoid coumarate esters isolated from Dalbergia trichocarpa, a tropical legume from Madagascar. Indeed, oleanolic aldehyde coumarate at 200 μM inhibits the formation/maintenance of P. aeruginosa PAO1 biofilm and the expression of the las and rhl QS systems as well as gacA gene [96] . Consequently, the production of QS-controlled virulence factors, including, rhamnolipids, pyocyanin, elastase, and extracellular polysaccharides, as well as twitching and swarming motilities is reduced. Other African plants harbor terpenoids and triterpenoids with antivirulence properties. Indeed, cassipourol and β-sitosterol (both at 100 μM), isolated from Platostoma rotundifolium (Briq.) A. J. Paton, a Burundian medicinal plant, inhibit quorum sensing-regulated and -regulatory gene expression in las and rhl systems. These triterpenoids can still disrupt the formation of biofilms at concentrations down to 12.5 and 50 μM [97].
Isothiocyanates and organosulfur compounds
Isothiocyanates produced by many plants are also QS inhibitors in P. aeruginosa PAO1. For example, iberin, isolated from horseradish (Armoracia rusticana G. Gaertn et al.), specifically blocks the expression of QS-regulated genes in P. aeruginosa PAO1 at the concentration of 100 μM; its impact on biofilm formation has not been investigated [98] . Sulforaphane and erucin, two isothiocyanates isolated from Natural Compounds Inhibiting Pseudomonas aeruginosa Biofilm Formation by Targeting… DOI: http://dx.doi.org /10.5772/intechopen.90833 broccoli, inhibit the P. aeruginosa PAO1 las and rhl system as well as biofilm formation at concentrations of 50 and 100 μM, respectively [99] .
A further compound known to affect the QS-regulated genes in P. aeruginosa, including the rhamnolipids production, is ajoene, an allyl sulfide isolated from Allium sativum L. Ajoene, at the concentration of 100 μg/mL and combined with the antibiotic tobramycin, leads to killing of biofilm-encapsulated P. aeruginosa. In a mouse model of pulmonary infection, this synergy improves the clearance of P. aeruginosa from lungs [100] . The S-phenyl-L-cysteine sulfoxide and its derivatives, notably diphenyl disulfide, have shown a significant impact on the biofilm formation by P. aeruginosa [101] ; the sulfoxide derivative seems to interfere with both las and rhl systems whereas the diphenyl sulfide only disturbs the las system.
From marine organisms
Furanones
A series of studies have indicated that marine organisms are a potential source of anti-QS [102] [103] [104] . The halogenated furanones produced by the red alga Delisea pulchra inhibit QS-induced activities in bacteria by competing with AHL signals related to their receptor site (LuxR) [104] . This protein-ligand binding is destabilized, causing rapid receptor recycling [102] . Inspired from natural compounds, the halogenated furanones C-30 and C-56 have been demonstrated to exhibit biofilm reduction and target the las and rhl systems in P. aeruginosa [105] .
Terpenoids
Following a screening of 284 extracts from the marine sponge Luffariella variabilis, 36 extracts were revealed as inhibitors of P. aeruginosa QS, targeting the las system [103] ; from these, the sesterterpenoids manoalide displays antibiofilm activities. Note that this molecule does not generate bactericidal effects on P. aeruginosa [103] , but presents an antibiotic activity against Gram-positive bacteria [106] .
From animals and human
Enzymes
Type I porcine kidney acylase inactivates QS signals such as C6-HSL and 3-oxo-C12-HSL but not C4-HSL [50] . This type I acylase moderately reduces biofilm formation in Aeromonas hydrophila, P. putida, and probably P. aeruginosa [107] . This degradation is dependent on the length of the acyl chain, since only C6-HSL and 3-oxo-C12-HSL are degraded [108] .
Mammalian cells release enzymes called paraoxonases 1 (extracted from human and murine sera) that have lactonase activity; degrading P. aeruginosa AHLs. They prevent, in an indirect way, QS and biofilm formation [109] . Similarly, human epithelial cells and particularly human respiratory epithelia have the capacity to inactivate a P. aeruginosa QS signal by inactivating AHLs (3-oxo-C12HSL) produced by P. aeruginosa [108, 110] . However, the enzyme or enzyme-like compound involved in acyl-homoserine lactone inactivation have not been identified and characterized yet. Recently, Losa et al. [111] demonstrated that polarized airway epithelial monolayers, in contrast to nonpolarized cells, are also able to degrade 3-oxo-C12-HSL using membrane-associated paraoxonase 2 that catalyzes the opening of the lactone ring.
Alkaloids
The P. aeruginosa pyocyanin production is inhibited by a molecule found and isolated from the ant Solenopsis invicta, the piperidine alkaloid Solenopsin A alkaloid. The biofilm formation is also reduced in a dose-dependent manner. This molecule probably disrupts the signals from the rhl system [112] .
Concluding remarks
This review presents natural compounds reported to exhibit anti-QS and antibiofilm properties against P. aeruginosa (summarized in Table 1 ); these highlight the great potentiality of living organisms as reservoir of compounds susceptible to modulate virulence mechanisms without affecting bacterial viability. Overall, it appears that prokaryotes as well as animals and humans are sources for enzymes that degrade or antagonize AHLs, whereas plants harbor larger panels of anti-QS and antibiofilm compounds with very diverse chemical structures, including alkaloids, organosulfurs, phenolics, and terpenoids. Contrarily to animals and humans, plants are not able to deploy elaborate defense through humoral and cell-mediated immunity (antibodies and phagocytes) to struggle against bacterial invasions [113] . Plants immune defenses rely on the secretion of antibacterial compounds (bactericide and/or bacteriostatic agents [114] ), including resistance modulating compounds [115] (e.g., inhibitors of efflux pumps [116] ), and mostly on their ability to recognize molecules released from pathogens through plant cell surface receptors. This recognition triggers specific signaling cascades, activating series of defense responses, including the synthesis of antimicrobial lytic proteins, enzymes, phytoalexins, and other secondary metabolites. Some of these exert nonmicrobicidal antivirulence properties [117, 118] . Finally, marine organisms and fungi produce also bioactive secondary metabolites (halogenated furanones and antibiotics, respectively) and other original and promising compounds, such as terrein which was identified as the first dual inhibitor of QS and c-di-GMP signaling at 30 μM.
The increasing presence of antibiotic-resistant bacteria certainly pushes scientists to reorient the strategy of fight against bacterial infections to defer entry into a post-antibiotic era where major antibiotics would not be effective even for banal infections. Antivirulence approaches and antivirulence drugs are being increasingly considered as potential therapeutic alternatives and/or adjuvants to currently failing antibiotics. For example, oleanolic aldehyde coumarate and cassipourol, anti-QS compounds, exert interesting antibiofilm properties, restoring the effectiveness of the antibiotic tobramycin in the clearance of biofilm-encapsulated P. aeruginosa (Figure 4) ; also the association between biofilm formation and antimicrobial resistance has been highlighted in carbapenem-resistant P. aeruginosa [119] . Such nonmicrobicidal drugs inhibit virulence factors essential for establishing infection and pathogenesis through targeting nonessential metabolic pathways which should not lead to activation of bacterial evasion mechanisms. This approach should reduce the selective pressure and consequently could slow down the development of resistance. Compounds that target QS may be particularly interesting as they impact planktonic and biofilm lifestyles, by reducing at the same time the production of virulence factors and the generation of biofilms. This should lead to less severe infections at levels that can be cleared by the host's immune defense and with increased activity of antibiotics.
Despite these important prospects, however, the big breakthrough in antibacterial strategies is still out of reach. This is probably due to a very complex [12] . Millenia of coevolution between plants and bacteria have led to complex defense strategies, with plants producing cocktails of bioactive compounds with multiple targets [114] and/ or compounds such as terrein that impact dual inhibitory targets. In the current state of research, much remains to be done in understanding these mechanisms and the real impact of such combinations before arriving at a commercial use. Nevertheless, following a combined approach for "adjuvant antibiotherapy" and "combined antibiotherapy" will undeniably lead to a renewed concept of "complex drugs for complex diseases," a well-known presupposed in traditional medicines [120] . © 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
